Markus Fluck

Merck (Germany) — Germany

Chemistry · Physical Sciences

16h-index893citations30works16.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Analytical Chemistry and Chromatography(11), Chronic Lymphocytic Leukemia Research(5), Mass Spectrometry Techniques and Applications(4), Pharmacogenetics and Drug Metabolism(3), Drug Transport and Resistance Mechanisms(3)

Publications30 total

Asia‐Inclusive Global Development of Enpatoran: Results of an Ethno‐Bridging Study, Intrinsic/Extrinsic Factor Assessments and Disease Trajectory Modeling to Inform Design of a Phase II Multiregional Clinical Trial
Clinical Pharmacology & Therapeutics·2024· 16 citedOpen Access
Cladribine as a Potential Object of Nucleoside Transporter-Based Drug Interactions
Clinical Pharmacokinetics·2021· 10 citedOpen Access
Pharmacodynamic biomarkers of long-term interferon beta-1a therapy in REFLEX and REFLEXION
Journal of Neuroimmunology·2021· 9 citedOpen Access
Review of Transporter Substrate, Inhibitor, and Inducer Characteristics of Cladribine
Clinical Pharmacokinetics·2021· 8 citedOpen Access
Avelumab internalization by human circulating immune cells is mediated by both Fc gamma receptor and PD-L1 binding
OncoImmunology·2021· 33 citedOpen Access
195 Avelumab internalization and lysosomal degradation by circulating immune cells in human is mediated by both Fc gamma Receptor (FcgR) and PD-L1 binding
Regular and Young Investigator Award Abstracts·2020· 2 citedOpen Access
P0301FIT FOR PURPOSE VALIDATION OF A CLINICAL ASSAY FOR THE DETECTION OF SERUM LEVELS OF GALACTOSE-DEFICIENT IMMUNOGLOBULIN A1 (GD-IGA1) IN PATIENTS WITH IGA NEPHROPATHY (IGAN)
Nephrology Dialysis Transplantation·2020
Correction to: The Clinical Pharmacology of Cladribine Tablets for the Treatment of Relapsing Multiple Sclerosis
Clinical Pharmacokinetics·2018Open Access
The Clinical Pharmacology of Cladribine Tablets for the Treatment of Relapsing Multiple Sclerosis
Clinical Pharmacokinetics·2018· 70 citedOpen Access
In vitro and in vivo drug disposition of cilengitide in animals and human
Pharmacology Research & Perspectives·2016· 9 citedOpen Access
In Vitro Characterization of Sarizotan Metabolism: Hepatic Clearance, Identification and Characterization of Metabolites, Drug-Metabolizing Enzyme Identification, and Evaluation of Cytochrome P450 Inhibition
Drug Metabolism and Disposition·2010· 6 cited
Pharmacokinetics of sarizotan after oral administration of single and repeat doses in healthy subjects
International Journal of Clinical Pharmacology and Therapeutics·2007· 6 cited
Investigation of sarizotan’s impact on the pharmacokinetics of probe drugs for major cytochrome P450 isoenzymes: a combined cocktail trial
European Journal of Clinical Pharmacology·2006· 25 cited
Selective Detection Of Nitrogen- And Oxygen Containing Volatile Organic Compounds (voc's)-. Use Of Metal-modified Polysiloxanes From Chromatography As Sensor Coatings
Proceedings of the International Solid-State Sensors and Actuators Conference - TRANSDUCERS '95·2005
Gene expression profile of unloaded rat soleus muscle in response to acetyl-L-carnitine supplementation
2005
Enantiomer separation by complexation SFC on immobilized Chirasil-nickel and Chirasil-zinc
Journal of Biochemical and Biophysical Methods·2000· 23 cited
ChemInform Abstract: Endothelin Antagonists. Part 3. Discovery of EMD 122946, a Highly Potent and Orally Active ET<sub>A</sub> Selective Antagonist.
ChemInform·1998
3. Endothelin antagonists: discovery of EMD 122946, a highly potent and orally active ETA selective antagonist
Bioorganic & Medicinal Chemistry Letters·1998· 15 citedOpen Access
Dynamic phenomena involving chiral dimethyl-2,3-pentadienedioate in enantioselective gas chromatography and NMR spectroscopy
Tetrahedron Asymmetry·1997· 29 cited
Selective detection of nitrogen and oxygen containing volatile organic compounds: use of metal-modified polysiloxanes as sensor coatings
Analytica Chimica Acta·1997· 24 cited
page 1 of 2Next →

Frequent Co-authors

Volker Schurig(13), Martin Jung(5), Róbert Hermann(4), Alain Munafo(4), Sabine Mayer(3), Simona Negura(3), Hansjörg Jakubetz(3), Alexandra Glausch(3), Hulin Jin(3), Vittorio D’Urso(3), Hugues Dolgos(3), Mats O. Karlsson(2), Ana Novaković(2), Nadia Terranova(2), Berend Neuteboom(2), Sean D. McKenna(2), Rene Schweickhardt(2), Alec W. Gross(2), Yves Fomekong Nanfack(2), Lars Toleikis(2)